3 months per 10 molecules to deliver predictions
* average Phase Advance customer cost
Phase Advance’s nonlinear mathematical models of disease progression are the core of our advancement, and our AI has been custom-built over decades to accelerate our predictions. We started with science, modeling human biology in its natural, nonlinear functions, and utilized AI not to extrapolate how the human body works, but to seek patterns within individual day-to-day patient response to drugs.
We quantitatively map out the entire drug development process (preclinical and clinical) by first predicting the individual-patient level clinical response rates, best biomarkers, optimal doses, and how well each drug will perform versus other candidate drugs, before the preclinical stage.
